No abstract available
Publication types
-
News
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenosine Triphosphate / physiology
-
Animals
-
Anions / chemistry
-
Anions / pharmacology
-
Anti-Infective Agents / chemistry
-
Anti-Infective Agents / pharmacology
-
Anti-Infective Agents / therapeutic use
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Binding Sites / drug effects
-
Binding, Competitive
-
Casein Kinase II / antagonists & inhibitors*
-
Casein Kinase II / chemistry
-
Casein Kinase II / physiology
-
Catalytic Domain / drug effects
-
Clinical Trials, Phase II as Topic
-
Combinatorial Chemistry Techniques
-
Humans
-
Metal Nanoparticles / chemistry*
-
Metal Nanoparticles / therapeutic use
-
Mice
-
Models, Molecular
-
Neoplasm Proteins / antagonists & inhibitors
-
Neoplasms / drug therapy
-
Neoplasms / enzymology
-
Oxygen Compounds / chemistry
-
Oxygen Compounds / pharmacology*
-
Oxygen Compounds / therapeutic use
-
Protein Conformation
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / pharmacology*
-
Transition Elements / chemistry
-
Transition Elements / pharmacology*
-
Transition Elements / therapeutic use
-
Xenograft Model Antitumor Assays
Substances
-
Anions
-
Anti-Infective Agents
-
Antineoplastic Agents
-
Neoplasm Proteins
-
Oxygen Compounds
-
Protein Kinase Inhibitors
-
Transition Elements
-
Adenosine Triphosphate
-
Casein Kinase II